ESG Report 2024

31 Environmental, Social and Governance Report 2024 The United Laboratories International Holdings Limited Assisting Customers in Developing Countries to Improve Product Quality Enhancing Healthcare Standards 6.4 6.4.1 Providing Training for Local Healthcare Professionals The Group actively promotes the development of pharmaceutical undertakings and is committed to facilitating academic exchange and information dissemination in the pharmaceutical field. The Group continues to provide technical training for healthcare workers in multiple low- and middle-income countries and regions, aiming to strengthen local health systems and enhance medical technical capabilities. During the Year, the Group participated in several high-level pharmaceutical academic forums, including the Annual Conference of the Diabetes Committee of the Chinese Research Hospital Association, the Meeting of the Diabetes and Endocrinology Committee of the Chinese Women Doctors' Association, and the Academic Conference on Diabetes Education and Management of the Chinese Medical Association. During the Year, the Group participated in a total of 21 national advanced academic forums, with the number of participants exceeding 2,000. Furthermore, the national public welfare training activity "Double Excellence Initiative" - Primary Diabetes Prevention and Management Training Program, organised by the Diabetes Committee of the Chinese Research Hospital Association and exclusively supported by the Group, continued to be held in the reporting period, making positive contributions to improving the rational clinical use of diabetes medications. Adhering to the tenet of "To Make Life More Valuable", the Group places a great importance to public health and supports the provisions of the “Doha Declaration on the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and Public Health” on protecting public health and granting compulsory licences for relevant patents in emergency situations. In addition, as a generic drug manufacturer, the Group supports fair competition for generic drugs and provides the public with more affordable choice of quality drugs. 6.4.2 Assisting Overseas Customer in Achieving International Pharmaceutical Manufacturing Standards As a raw material supplier, the Group not only provides high quality APIs and intermediates to large pharmaceutical enterprises in developed countries, but also continuously to assist pharmaceutical companies in developing and less developed countries to upgrade their pharmaceutical manufacturing standards. Through the provision of detailed formulation information, shipment of samples and working controls, as well as the provision of technical improvement support, we help our customers, including local pharmaceutical manufacturers, to improve their production efficiency and effectively control the quality and stability of their pharmaceutical products. The Group is committed to assisting its customers in meeting the developed national and international pharmaceutical manufacturing standards and promoting the common progress of the global pharmaceutical industry. Our clients in Thailand faced challenges in their production of Amoxicillin’s raw materials due to limitations in their manufacturing technology, leading to frequent dissolution issues. Through multiple communications and negotiations, we arranged for free samples and shared relevant production parameters to assist the client in improving production efficiency and ensuring quality stability. Providing Process Technology Improvement Support to Clients A client of the Group’s in Paraguay had used substandard oral Amoxicillin and Cefixime Proxetil, resulting in a serious medical incident and even the death of a child. After investigation, it was found that the original supplier of the customer was a chemical factory with insufficient quality control, and the customer lacked a comprehensive internal quality management system. In order to solve this problem, the Group initiated in-depth communication with the customer, provided detailed information on the preparations, and equipped each shipment with reference standards to help the customer effectively control the quality of the drugs during the production process. Through continuous technical support and quality management guidance, we successfully assisted the customer in upgrading the production standard of the preparation to that of developed countries.